Leveraging Social Determinants of Health to Enhance Recruitment of Underrepresented Populations in Clinical Trials
{{output}}
Historically marginalized communities are disproportionately affected by cardiometabolic diseases yet are underrepresented in clinical trials that investigate needed interventions. This review investigates the barriers to equitable inclusion in clinical trials... ...
